Suppr超能文献

[含钙肝素注射后医源性皮肤及皮下钙化症两例]

[Two cases of iatrogenic cutis and subcutis calcinosis after calcium-containing heparin injection].

作者信息

Bonnecarrère L, Templier I, Carron P-L, Maurizi J, Salameire D, Beani J-C, Blaise S

机构信息

Service d'anatomie pathologique et cytologique, pôle pluridisciplinaire de médecine, clinique universitaire de dermato-vénérologie, photobiologie et allergologie, hôpital Albert-Michallon, CHU de Grenoble, BP 217, 38043 Grenoble cedex 09, France.

出版信息

J Mal Vasc. 2009 Nov;34(5):366-71. doi: 10.1016/j.jmv.2009.08.001. Epub 2009 Sep 25.

Abstract

BACKGROUND

Subcutis calcinosis, characterized by abnormal calcium deposition in the skin, is a rare side effect of calcium containing heparins.

PATIENTS AND METHODS

Two patients with renal failure presented skin lesions after receiving a calcium-containing heparin treatment. The first patient exhibited erythematous nodules on the abdomen and the second a large erythematous induration of the abdomen and nodules on the thighs. Both had normal blood analysis. The diagnosis of subcutis calcinosis was confirmed by the histological exam showing calcium deposit in the dermis and hypodermis. Outcome was unfavourable in one of the patients who developed a superinfection and skin necrosis lesion requiring surgery at 2 months.

DISCUSSION

Subcutis calcinosis is a rare and probably underdiagnosed disease. To our knowledge, only 10 cases have been reported. The pathogenesis is not well-known, tissue damage and calcium disorders are considered as risk factors. The differential diagnoses that can be suspected include calciphylaxis, such as calcifying panniculitis and other local side effects of heparins. Outcome is usually favourable without treatment.

CONCLUSION

We describe two cases of iatrogenic subcutis calcinosis after injections of calcium-containing heparins, including the second case of poor outcome. Clinicians should be aware of this adverse effect since other heparins such as fondaparinux or low-weight molecular heparins are contraindicated in patients with renal failure, leading to a large prescription of calcium-containing heparins in this population.

摘要

背景

皮下钙质沉着症,其特征为皮肤中异常的钙沉积,是含钙肝素的一种罕见副作用。

患者与方法

两名肾衰竭患者在接受含钙肝素治疗后出现皮肤病变。首例患者腹部出现红斑结节,第二例患者腹部出现大片红斑硬结,大腿出现结节。两人血液分析均正常。皮下钙质沉着症的诊断通过组织学检查得以证实,显示真皮和皮下组织中有钙沉积。其中一名患者病情发展不利,在2个月时出现了需要手术治疗的二重感染和皮肤坏死病变。

讨论

皮下钙质沉着症是一种罕见且可能诊断不足的疾病。据我们所知,仅报告了10例。其发病机制尚不明确,组织损伤和钙代谢紊乱被视为危险因素。可能怀疑的鉴别诊断包括钙化防御,如钙化性脂膜炎以及肝素的其他局部副作用。通常未经治疗病情也会好转。

结论

我们描述了两例注射含钙肝素后发生的医源性皮下钙质沉着症病例,包括第二例预后不良的病例。临床医生应意识到这种不良反应,因为在肾衰竭患者中,其他肝素如磺达肝癸钠或低分子肝素是禁忌的,这导致该人群大量使用含钙肝素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验